Further results confirmed that AGAP2-AS1 is packaged into exosomes by hnRNPA2B1 and this way transfers trastuzumab resistance to sensitive breast cancer cells (Zheng et al., 2019). This evidence concerns the gene AGAP2 and breast cancer.